Table 1 Summary of the key epidemiological characteristics of the studies selected
Reference | Country | Total patients (% of women) | Mean age (SD) | Scale assessing depression | Scale assessing migraine |
|---|---|---|---|---|---|
Maasumi et al. [20] | USA | 359 (86.1%) | 45.1 (13.2) | PHQ-9 | HIT6 |
Boudreau et al. [21] | Canada | 32 (87.5%) | 42.4 (12.4) | PHQ-9, BDI-II | HIT6, MIDAS, VAS |
Kollewe et al. [22] | Germany | 27 (92.3%) | 45.6 (10.8) | BDI | HIT6 |
Russo et al. [19] | Italy | 52 (88.5%) | 48.7 (12.9) | BDI-II | MIDAS |
Demiryurek et al. [23] | Turkey | 60 (73.3%) | 34.7 (6.4) | BDI | MIDAS, VAS |
Guerzoni et al. [24] | Italy | 57 (80.7%) | 54.2 (13) | Zung-D | HIT6, VAS |
Aydinlar et al. [18] | Turkey | 190 (87.9%) | 39.3 (10.2) | DASS-21 | MIDAS |
Blumenfeld et al. [25] | USA | 715 (84.8%) | 43.0 (11.3) | PHQ-9 | None |